Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 202

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 202
---
ash equity issuance costs of approximately $ 5.2million. As of December 31, 2024, there are 80,940Class D Common Stock Warrants outstanding to purchase 5,060shares of common stock that were not included in the Class D Warrant Inducement. Class E Warrant Inducement On December 3, 2024, the Company entered into warrant exercise inducement offer letters (the “December 2024 Inducement Letters”) with the holders of the Class E Common Stock Warrants (the “Class E Holders”) for 4,064,040existing Class E Common Stock Warrants exercisable for an aggregate of 254,002shares of common stock (the “Class E Common Stock Existing Warrants”), to exercise their warrants at an exercise price of $ 16.00per share, in exchange for the Company’s agreement to issue 4,064,040Class F Common Stock Warrants for 254,002shares of its common stock (the “Class F Common Stock Warrants”) and 6,096,060Class G Common Stock Warrants for 381,004shares of its common stock (the “Class G Common Stock Warrants”). The aggregate net proceeds from the exercise of the Class E Common Stock Existing Warrants, was $ 3.7million. F-15 REVELATION BIOSCIENCES, INC.
Notes to the Consolidated Financial Statements 6. 2024 Public Offering(cont.) In consideration for the immediate exercise of the Class E Common Stock Existing Warrants for cash, the exercising holders received one Class F Common Stock Warrants for each Class E Common Stock Existing Warrant and one and a half Class G Common Stock Warrants for each Class E Common Stock Existing Warrant in a private placement pursuant to Section 4(a)(2) of the Securities Act. The Class F Common Stock Warrants are exercisable for a period of twoyears as of the date that shareholder approval is obtained into an aggregate of up to 254,002shares of common stock at an exercise price of $ 16.00per share. The Class F Warrants have an alternative cashless exercise provision that allows the holder thereof to receive twoshares of common stock without payment of the exercise price. The Class G Common Stock Warrants are exercisable for a period of fiveyears as of the date that Shareholder approval is obtained into an aggregate of up to 381,004shares of common stock at an exercise price of $ 16.